Physiopathological significance of catalytic phospholipids in the generation of thrombin

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 2, 1996, Pages 157-164

  Dachary Prigent, Jeanne ^a   Toti, Florence ^b   Satta, Nathalie ^b   Pasquet, Jean Max ^a   Uzan, André ^c   Freyssinet, Jean Marie ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c SANOFI   (France)

Author keywords

Membrane asymmetry; Phosphatidylserine; Scott syndrome; Tissue factor; Vesiculation

Indexed keywords

PHOSPHATIDYLSERINE; THROMBIN;

BLOOD CLOTTING; CONFERENCE PAPER; ENZYME ACTIVITY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOGENESIS; THROMBOSIS;

EID: 0029894778     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999004     Document Type: Conference Paper

References (58)

1. Ruf W, TS Edgington: Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 8:385-390, 1994.
2. Mann KG, S Krishnaswamy, JH Lawson: Surface-dependent hemostasis. Semin Hematol 29:213-226, 1992.
3. Zwaal RFA, P Comfurius, EM Bevers: Mechanism and function of changes in membrane phospholipid asymmetry in platelets and erythrocytes. Biochem Soc Trans 21:248-253, 1993.
4. Neuenschwander PF, MM Fiore, JH Morrissey: Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. J Biol Chem 268:21489-21492, 1993.
5. Forman SD, Y Nemerson: Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: Fluid phase factor X regulates the extrinsic system. Proc Natl Acad Sci USA 83:4675-4679, 1986.
6. Krishnaswamy S, KA Field, TS Edgington, JH Morrissey, KG Mann: Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem 267:26110-26120, 1992.
7. Bach R, DB Rifkin: Expression of tissue factor procoagulant activity: Regulation by cytosolic calcium. Proc Natl Acad Sci USA 87:6995-6999, 1990.
8. Furie B, BC Furie: Molecular and cellular biology of blood coagulation. N Engl J Med 326:800-806, 1992.
9. Zwaal RFA, EM Bevers, J Rosing: Phospholipids and the clotting process. In: Harris EN, T Exner, GVR Hughes, RA Asherson (Eds): Phospholipid-Binding Antibodies. CRC Press, Boca Raton, FL, 1991, pp 31-56.
10. Hemker HC, RFA Zwaal: Heterogeneous biocatalysis in the generation of thrombin. Trends Biochem Sci 7:378-381, 1982.
11. Devaux PF: Static and dynamic lipid asymmetry in cell membranes. Biochemistry 30:1163-1173, 1991.
12. Devaux PF: Protein involvement in transmembrane lipid asymmetry. Annu Rev Biophys Biomol Struct 21:417-439, 1992.
13. Hawiger J, LF Brass, EW Salzman: Signal transduction and intracellular regulatory processes in platelets. In: Colman R, J Hirsh, VJ Marder, EW Salzman (Eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Lippincott, Philadelphia, 1994, pp 603-628.
14. Bassé F, P Gaffet, F Rendu, A Bienvenüe: Translocation of spin-labeled phospholipids through plasma membrane during thrombin- and ionophore A23187-induced platelet activation. Biochemistry 32:2337-2344, 1993.
15. Sheetz MP, SJ Singer: Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci USA 71:4457-4461, 1974.
16. Fox JEB, CD Austin, CC Reynolds, PK Steffen: Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 266:13289-13295, 1991.
17. Sims PJ, T Wiedmer, CT Esmon, HJ Weiss, SJ Shattil: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 264:17049-17057, 1989.
18. Chang C-P, J Zhao, T Wiedmer, PJ Sims: Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 268:7171-7178, 1993.
19. Kelton JG, TE Warkentein, CPM Hayward, WG Murphy, JC Moore: Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood 80:2246-2251, 1992.
20. Sims PJ, EM Faioni, T Wiedmer, SJ Shattil: Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263:18205-18212, 1988.
21. Fox JEB: Shedding of adhesion receptors from the surface of activated platelets. Blood Coag Fibrinolysis 5:291-304, 1994.
22. 1 integrins in platelets and platelet-derived microvesicles. Blood 82:1197-1203, 1993.
23. Hamilton KK, R Hattori, CT Esmon, PJ Sims: Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 265:3809-3814, 1990.
24. Robinson RA, L Worfolk, PB Tracy: Endotoxin enhances the expression of monocyte prothrombinase activity. Blood 79:406-416, 1992.
25. Satta N, F Toti, O Feugeas, A Bohbot, J Dachary-Prigent, V Eschwège, H Hedman, J-M Freyssinet: Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 153:3245-3255, 1994.
26. Weiss HJ: Inherited abnormalities of platelet granules and signal transduction. In: Colman R, J Hirsh, VJ Marder, EW Salzman (Eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Lippincott, Philadelphia, 1994, pp 673-684.
27. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: A study of the red blood cells of Scott syndrome. Blood 79:380-388, 1992.
28. Swords NA, PB Tracy, KG Mann: Intact platelet membranes, not platelet-released microvesicles, support the procoagulant activity of adherent platelets. Arterioscler Thromb 13:1613-1622, 1993.
29. Nomura S, M Yanabu, H Kido, T Fukori, K Yamagushi, T Soga, H Nagata, T Kokawa, K Yasunaga: Antiplatelet autoantibody-related microparticles in patients with idiopathic (autoimmune) thrombocytopenic purpura. Ann Hematol 62:103-107, 1991.
30. Bode AP, SM Orton, MJ Frye, BJ Udis: Vesiculation of platelets during in vitro aging. Blood 77:887-895, 1991.
31. Jy W, LL Horstman, M Arce, YS Ahn: Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 119:334-345, 1992.
32. Borenstain-Ben Yashar V, Y Barenholz, E Hy-Am, EA Rachmilewitz, A Eldor: Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 44:63-65, 1993.
33. Wiedmer T, SE Hall, TL Ortel, WH Kane, WF Rosse, PJ Sims: Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82:1192-1196, 1993.
34. Lee Y, W Jy, LL Horstman, J Janiana, Y Reyes, RE Kelley, YS Ahn: Elevated microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 72:295-304, 1993.
35. Galli M, EM Bevers, P Comfurius, T Barbui, RFA Zwaal: Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microparticles. Br J Haematol 83:466-472, 1993.
36. Jy W, L Horstman, M Mao, Y Ahn: Platelet microparticles adhere to polymorphonuclear leukocytes: Possible mode of clearance. (Abst.) Blood 82:281a, 1993.
37. Jy W, LL Horstman, F Wang, YS Ahn: Procoagulant activity of platelet microparticles (PAPM) correlates with thrombotic risks. (Abst.) Blood 82:281b, 1993.
38. Horstman LL, W Jy, DR Schulte, WW Mao, YS Ahn: Complement-mediated fragmentation and lysis of opsonized platelets: Gender differences in sensitivity. J Lab Clin Med 123:515-525, 1994.
39. Zucker-Franklin D: Clinical significance of platelet microparticles. J Lab Clin Med 119:321-322, 1992.
40. Cines D, SJ Shattil: Sex hormones, complement-mediated platelet damage, and hemostasis. J Lab Clin Med 123:464-466, 1994.
41. Savill J, V Fadok, P Henson, C Haslet: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131-136, 1993.
42. Tans G, J Rosing, MCLDG Thomassen, M-J Heeb, RFA Zwaal, JH Griffin: Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 77:2641-2648, 1991.
43. Nomura S, M Yanabu, T Fukuroi, H Kido, T Kawakatsu, K Yamagushi, M Suzuki, T Kokawa, K Yasunaga: Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura. Ann Hematol 65:46-49, 1992.
44. Zwaal RFA, P Comfurius, EM Bevers: Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1180:1-8, 1992.
45. Raynal P, HB Pollard: Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197:63-93, 1994.
46. Huber R, R Berendes, A Burger, M Schneider, A Karshikov, H Luecke: Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins. J Mol Biol 223:683-704, 1992.
47. Mosser G, C Ravanat, J-M Freyssinet, A Brisson: Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J Mol Biol 217:241-245, 1991.
48. Ravanat C, J Torbet, J-M Freyssinet: A neutron solution scattering study of the structure of annexin-V and its binding to lipid vesicles. J Mol Biol 226:1271-1278, 1992.
49. Pigault C, A Follenius-Wund, M Schmutz, J-M Freyssinet, A Brisson: Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes. J Mol Biol 236:199-208, 1994.
50. Thiagarajan P, JF Tait: Collagen-induced exposure of anionic phospholipids in platelets and platelet-derived microparticles. J Biol Chem 266:24302-24307, 1991.
51. Dachary-Prigent J, J-M Freyssinet, J-M Pasquet, J-C Carron, AT Nurden: Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 81:2554-2565, 1993.
52. Ravanat C, G Archipoff, A Beretz, G Freund, J-P Cazenave, J-M Freyssinet: Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem J 282:7-13, 1992.
53. Van Heerde WL, KS Sakariassen, HC Hemker, JJ Sixma, CPM Reutelingsperger, PG de Groot: Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions. Arteriosclerosis Thromb 14:824-830, 1994.
54. Römisch J, E-P Pâques: Annexins: Calcium-binding proteins of multi-functional importance? Med Microbiol Immunol 180:109-126, 1991.
55. Suttie JW: Vitamin K antagonists. In: Colman R, J Hirsh, VJ Marder, EW Salzman (Eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Lippincott, Philadelphia, 1994, pp 1562-1566.
56. Hirsh J, JS Ginsberg, VJ Marder: Anticoagulant therapy with coumarin agents. In: Colman R, J Hirsh, VJ Marder, EW Salzman (Eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Lippincott, Philadelphia, 1994, pp 1567-1583.
57. Nomura S, Y Komiyama, T Miyake, Y Miyazaki, H Kido, M Suzuki, H Kagawa, M Yanabu, H Takahashi, S Fukuhara: Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemostas 72:519-522, 1994.
58. Davis-Salinas J, SM Saporito-Irwin, FM Donovan, DD Cunningham, WE Van Nostran: Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid β-protein precursor. J Biol Chem 269:22623-22627, 1994.